Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 639.53 Delayed Data As of Jul 07 |  +12.28 / +1.96%Today’s Change | 271.37 Today|||52-Week Range 653.63 | +70.32% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $63.7B |
Company Description
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Contact Information
Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown New York 10591-6707 |
Employees
Shareholders
| Mutual fund holders | 54.29% |
| Individual stakeholders | 23.74% |
| Other institutional | 15.46% |
Top Executives
| There are no executives to display. |
